Stevenage Bioscience Catalyst
Stevenage Bioscience Catalyst is the UK’s first open innovation bioscience campus, pioneering a unique culture to drive early stage drug discovery and development, and is open for business. It is backed by £38m of funding from its founding partners – GlaxoSmithKline, the Wellcome Trust, the Department of Business, Innovation and Skills, the Technology Strategy Board and the East of England Development Agency. Buildings in Phase 1 of the development consist of an Incubator and an Accelerator, covering 60,000 sq ft of laboratory, office and networking space. The independent facility is expected to house a range of companies, from virtual and start-up firms to those which are more established. Located on the GlaxoSmithKline Stevenage site, Stevenage Bioscience Catalyst is in the unique position of operating in proximity to the expertise and resources of a major pharmaceutical company, close to both London and Cambridge. For more information, please go to www.stevenagecatalyst.com, or follow us on LinkedIn and twitter (@SteBioCat).
ConsultingInnovative Business Consulting
OBR-Consulting is a unique platform to meet the growing need for consultancy at the intersection of science, business and entrepreneurship.Learn more